ESRRA and breast cancer: Drug-induced inhibition of ERRα by C29 in the mouse cell lines NIC-5231 and NIC-5257, derived from ErbB2-driven mammary tumors [25], also led to a stark reduction in DNMT1 protein (Fig. 1i, j).